Assesses quality control methods for mRNA vaccines, suggesting improvements for immunobiologicals.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Azevedo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: